DarioHealth, a digital chronic-condition-management platform, reported $3.6 million in revenue for Q4 2023, compared to $6.8 million for the fourth quarter of 2022, a 47% decrease. Year-over-year revenue in 2023 was $20.4 million, compared to $27.7 million for 2022.
The New York-based company said the overall decrease in revenue stemmed from lower consumer and strategic-partner channels.
The...
Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform.
Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for chronic conditions where they see an unmet need and concerns around disease progression, like multiple sclerosis, hypertension,...
Chronic condition management platform Omada Health announced Wednesday it would include behavioral health support in its existing programs for diabetes prevention and management, hypertension, and musculoskeletal care.
The new behavioral health integration includes anxiety and depression assessment, resources to manage social determinants of health, like access to food, stress management and...
Drug discovery startup ArrePath announced Thursday it has raised $20 million in a seed funding round led by the Boehringer Ingelheim Venture Fund, Insight Partners and Innospark Ventures.
Other participants in the round include Viva BioInnovator, Arimed Capital, PTX Capital and Nor’easter Ventures. The company, which focuses on developing new types of anti-infective drugs to best antimicrobial...
Digital chronic condition management company Lark Health has closed a Series D funding round worth $100 million.
Deerfield Management Company led the raise, with participation from PFM Health Sciences and returning investors Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital and Marvell Technology cofounder Weili Dai.
With the money from its Series D round, Lark’s total...
Onduo Health, the virtual diabetes coaching program backed by Verily (and to a lesser extent Sanofi), announced this morning that it is expanding its platform beyond Type 2 diabetes to include several other conditions frequent among its populations.
Multi-condition services focused on hypertension, pre-diabetes, weight loss and mental wellbeing – as well as underlying coaching support for dieting...
Taiwan-based diabetes management app Health2Sync and DAIKYO ASTAGE INCORPORATED, a Japan-based apartment management company, has partnered to provide health management services to residents in DAIKYO ASTAGE managed apartments in Japan.
The partnership also includes two local pharmacies, Primary Pharmacy Co., Ltd. and Yakuju Co., Ltd., and will commence in the city of Kawasaki City, Kanagawa...
The current moment of health innovation and investment spurred by the COVID-19 crisis seems to be accelerating, if not driving, the consolidation of the digital health space. While Teladoc and Livongo loom as the most striking recent example, Omada’s purchase of Physera in May was also bolstered by the pandemic and its follow-on effects, CEO Sean Duffy told MobiHealthNews in a recent interview....
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers.
The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...
After their recent collaboration with Grab in August to ensure that medication is delivered within 90 minutes once the teleconsultation session is complete, Singapore-based digital health startup WhiteCoat announced earlier this week that they are partnering with Homage, an on-demand home caregiving services platform to launch a pilot telehealth programme that complements home-based care.
WHAT’S...
